Beijing, March 21, 2023——InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced that it will host a conference call to discuss the 2022 full year financial results and provide a corporate update at 9:30 a.m. and 8:00 p.m. Beijing time on March 28, 2023 respectively. Before the call, the Company will announce the financial results for the full year ended December 31, 2022.
Conference Call Information
InnoCare will host a conference call at 9:30 a.m. Beijing time in Chinese and at 8:00 p.m. Beijing time in English on March 28, 2023. Participants must register in advance of the conference call. Details are as follows:
For Chinese conference call, please register through the below link:
For English conference call, please register through the below link:
Please pre-register by clicking the above link at least 24 hours before the call.
InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases with unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, Hong Kong, and United States.